Study of Icotinib Hydrochloride in Treating Patients With Recurrent or Metastatic Esophageal Cancer After Failure of Conventional Chemotherapy

Condition:   Esophageal Squamous Cell Carcinoma
Intervention:   Drug: Icotinib Hydrochloride
Sponsor:   Yuhong Li
Recruiting - verified April 2016

from #ORL via xlomafota13 on Inoreader http://ift.tt/215t5Ze
via IFTTT